Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed ...

A new DNA test could spare millions of breast cancer patients from chemotherapy. We answer your questions about what it means ...

Advances in genomic testing are helping doctors identify which tumours truly need chemotherapy — and which patients may do ...

Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting ...

A new genetic test could help many women with breast cancer safely skip chemotherapy, reducing side effects while ensuring ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with the Alliance for Clinical Trials in Oncology to advance a national, ...

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...